#3118 on the rich list of 14,452 insiders
Marc Tessier-Lavigne
Director at Denali Therapeutics; Director at Regeneron Pharmaceuticals. Based in South San Francisco, California.
$38.0M
in disclosed stock, −$447K (−1.16%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 3118th of 14,452
- Companies held
- 2
- Largest holding
- DNLI, 94.1% of total
- Latest SEC filing
- Jun 3, 2025
What the $38.0M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Denali Therapeutics DNLI Common Stock | Directly | 1,886,576 | $18.20 | $34.3M | 90.3% | Form 4, Jun 3, 2025 |
| Regeneron Pharmaceuticals REGN Common Stock | Directly | 2,434 | $923.34 | $2.2M | 5.9% | Form 4, Jan 3, 2023 |
| Denali Therapeutics DNLI Common Stock | The Tessier-Lavigne/Hynes Irrevocable Trust 1 | 78,848 | $18.20 | $1.4M | 3.8% | Form 4, Jun 3, 2025 |
Share counts are the amounts Marc Tessier-Lavigne reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 3115 | Michael H. Train SVP & Chief Sustain Officer, Emerson Electric. St. Louis, MO | $38.1M |
| 3116 | Michael Dean Brown See Remarks, Travel + Leisure. Orlando, FL | $38.1M |
| 3117 | Albert Chao Executive Chairman, Westlake. Houston, TX | $38.1M |
| 3118 | Marc Tessier-Lavigne Director, Denali Therapeutics. South San Francisco, CA | $38.0M |
| 3119 | Mike Slessor CEO, FormFactor. Livermore, CA | $38.0M |
| 3120 | Chuong James Chief Financial Officer, Atlassian. San Francisco, CA | $38.0M |
| 3121 | Thomas C. Freyman Director, AbbVie. North Chicago, IL | $37.9M |
Other Denali Therapeutics insiders
All DNLI insiders- Ryan J. Watts$44.0MPresident and CEO. #2788 overall
- Steve Krognes$14.9MDirector. #6089 overall
- Alexander O. Schuth$14.9MCOFO and Secretary. #6473 overall
- Carole Ho$7.7MChief Medical Officer. #9813 overall
- Jay T. Flatley$6.5MDirector. #9871 overall
- Vicki L. Sato$2.0MDirector. #7843 overall
Questions
How much stock does Marc Tessier-Lavigne own?
Marc Tessier-Lavigne holds $38,018,126 in listed stock based on SEC filings and current prices, mostly Denali Therapeutics (DNLI). That ranks 3118th on the Stock Rich List.
Is this Marc Tessier-Lavigne's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.